
540737-29-9 Tofacitinib Citrate
CAS:540737-29-9
MF:C16H20N6O.C6H8O7
MW:504.497
EINECS:638-826-4
MDL No.:MFCD11616529
Properties
Melting point:201 °C (decomp)
storage temp. room temp
solubility DMSO: soluble5mg/mL (clear solution; warmed)
Appearance white to beige powder
Application:
Tofacitinib (CP-690550) Citrate is a novel JAK3 inhibitor with an IC50 of 1 nM, and its selectivity towards JAK2 and JAK1 is 20 to 100 times lower.
Synonyms:
Tofacitinib citrate
540737-29-9
Tasocitinib citrate
Xeljanz
Tofacitinib (CP-690550) Citrate
Tofacitinib (citrate)
Tasocitinib monocitrate
Tofacitinib monocitrate
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
1-Piperidinepropanenitrile, 4-methyl-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)- beta-oxo-, (3R,4R)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
2-hydroxypropane-1,2,3-tricarboxylic acid; 3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile
2-hydroxypropane-1,2,3-tricarboxylic acid;3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile
3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXO-PROPANENITRILE2-HYDROXYPROPANE-1,2,3-TRICARBOXYLATE (1:1)
3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile 2-hydroxypropane-1,2,3-tricarboxylate
3-{(3r,4r)-4-methyl-3-[methyl-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate salt
3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl}-amino]-piperidin-1-yl)-3-oxo-propionitrile citrate salt
Xeljanz (TN)
XELJANZXR
Tasocitinib citric acid salt
TOFACITINIB CITRATE [JAN]
C16H20N6O.C6H8O7
SYIKUFDOYJFGBQ-YLAFAASESA-N
Tofacitinib (citrate) (Standard)
TOFACITINIB MONOCITRATE [MI]
TOFACITINIB CITRATE [WHO-DD]
AKOS022178222
Tofacitinib citrate, >=98% (HPLC)
TOFACITINIB CITRATE [ORANGE BOOK]
CP 690550 citrate (Tofacitinib citrate)
Tofacitinib citrate (CP-690550 citrate)
(3R,4R)-4-Methyl-3-(methyl-7H-pyrro lo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidinepro panenitrile citrate
(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile 2-hydroxy-1,2,3-propanetricarboxylate
1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-, 2-HYDROXY-1,2,3-PROPANETRICARBOXYLATE
Hot Tags: 540737-29-9 tofacitinib citrate, China 540737-29-9 tofacitinib citrate manufacturers, suppliers, Selexipag intermediate, Cobalt carbonyl, 3 Trifluoromethyl benzaldehyde, 3 2 Aminoethyl 6 methoxyindole, Methylisocyanoacetate, N N Diethyl S S difluoro sulfiliminium tetrafluoroborate

